Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases
| Autor: | Jean-Marc Léger, Amena Ben Younes-Chennoufi, Djaouida Bengoufa, Thierry Maisonobe, Nicole Baumann, Pierre Bouche, Bénédicte Chassande |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Adult
Male Pathology medicine.medical_specialty Physiology medicine.drug_class Neural Conduction Paraproteinemias Muscle Proteins Monoclonal antibody Mononeuropathy Cellular and Molecular Neuroscience Recurrence Physiology (medical) medicine Humans Connectin Paresthesia Aged Autoantibodies Retrospective Studies Aged 80 and over Analysis of Variance biology business.industry Electromyography Patient Selection Autoantibody Peripheral Nervous System Diseases Middle Aged medicine.disease Axons IgM Monoclonal Gammopathy Electrophysiology Myelin-Associated Glycoprotein Peripheral neuropathy Myeloma Proteins Immunoglobulin M biology.protein Disease Progression Female Neurology (clinical) Antibody business Polyneuropathy |
| Zdroj: | Musclenerve. 21(1) |
| ISSN: | 0148-639X |
| Popis: | Forty cases of polyneuropathy associated with IgM monoclonal gammopathy were retrospectively studied to investigate the relevance of clinical and electrophysiological features to M-protein antibody activity. There were 26 men and 14 women; mean age was 65 +/- 11.7 years at the time of the study. Thirty-nine patients had a symmetrical polyneuropathy, of whom 13 had a predominantly sensory and 17 a purely sensory neuropathy (i.e., 30 sensory neuropathies). The remaining patient had a multifocal mononeuropathy. Electrophysiological studies allowed the polyneuropathies to be classified as demyelinating in 33 cases (82.5%) and axonal in 6 cases. Antibody studies disclosed anti-MAG antibodies in 65% and anti-SGPG antibodies in 82.5% of patients. Anti-MAG antibodies were associated with only demyelinating polyneuropathies. Anti-SGPG antibodies were found in 91% of demyelinating polyneuropathies and 50% of axonopathies. In addition, anti-MAG/SGPG antibody activity was significantly correlated with the subgroup of sensory neuropathies (P < 0.01). Last, antisulfatide antibodies were found at significant titers in 18 cases, and their presence was significantly correlated with anti-MAG/SGPG antibody activity, but not with some clinical/electrophysiological features. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text